Class 4 Drug Caution In Use - Beclometasone dipropionate 50 micrograms/dose Nasal Spray (Various Liveries)

Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ayrton-saunders-limited-beclometasone-dipropionate-50-micrograms-slash-dose-nasal-spray-various-liveries-el-22-a-slash-14?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=3cee273e-9974-4dab-91dc-ef9076df844b&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information and stock control queries please contact: Ayrton Saunders Ltd., 9 Arkwright Road, Astmoor Industrial Estate, Runcorn, Cheshire, WA7 1NU or quality@ayrtons.com

Class 4 Drug Caution In Use - Latuda film-coated tablets

CNX Therapeutics Ltd. have notified the MHRA that the batches of Latuda film-coated tablets listed in this notification will be released without EAN barcodes on the cartons.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-cnx-therapeutics-ltd-latuda-film-coated-tablets-el-22-a-slash-13?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=dac1ea2a-e6e3-4479-b1e3-e8b6894509b8&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For more information and medical information contact: medinfo@cnx-therapeutics.com

For stock control queries please contact: supplychain@cnx-therapeutics.com

Important update on operations in Eastern Europe

AmerisourceBergen - 15 March 2022

Leaders at AmerisourceBergen continue to monitor the international response and reaction to Russia’s invasion of Ukraine.

All operations in Ukraine remain suspended to ensure the safety of our team members, partners and customers. AmerisourceBergen will cease new business initiatives in Russia and Belarus while completing support of existing clinical trials and continuing distribution of oncology therapies and other pharmaceutical products.

We will continue to share more information as soon as it is available. Please keep checking this page for further updates. If you have any additional questions, please reach out to your local World Courier representative.

For more information about AmerisourceBergen’s current operations in Eastern Europe, please read this statement from Robert Mauch, Executive Vice President and Group President of AmerisourceBergen.

UPDATE on Chessington CD Deliveries

We are pleased to advise the earlier technical issue resulting in delays to Controlled Drug deliveries from Chessington service centre has now been fully resolved.

All outstanding CD orders will be delivered on Monday morning, there is no need to re-order. Should you have an emergency requirement, please contact Customer Service.

We apologise for the inconvenience caused, and thank you for your cooperation.

AmerisourceBergen and Alliance Healthcare - March 7, 2022

An Alliance Healthcare spokesperson said:

“Our thoughts are with the Ukrainian people whose resilience and fortitude is truly remarkable and inspirational to us all.  As the conflict in Ukraine continues, our priority has been – and will remain – to put the health of all team members and patients first.

Across all businesses within AmerisourceBergen, our team members are working with governments, associations and partners across Europe to understand and respond to the needs identified by Ukrainian authorities and humanitarian organisations, such as the World Health Organisation.

The safety and wellbeing of our eleven Word Courier colleagues in Ukraine is a priority and we provide all necessary support to them. They will remain in our thoughts in the days and weeks ahead.  

In alignment with AmerisourceBergen Foundation’s mission a commitment of $100,000 in grant donations have been deployed to support organizations on the ground in Ukraine to provide care and relief to those impacted by this conflict, including Direct Relief to support their emergency response in and around Ukraine.

The Foundation is also matching employee donations on a 2:1 basis to Direct Relief, International Committee of the Red Cross and the Ukraine Crisis Relief Fund at GlobalGiving. i.e. for every Euro donated by a colleague, the Foundation will donate two. The AB Foundation is committed to support relief efforts surrounding the Ukraine crisis over the long term. This donation is an initial step in these efforts.

Other support from our country businesses include:

• > Romania has initiated projects with Save the Children including providing support for mother and children refugees and a donation of infant formula and baby food along with giving 15,000 euros to hospitals in Ukraine on Romanian border and a further 15,000 euros to assist Ukrainian refugees in Romania.
• > Alloga in the Czech Republic is working with the Ministry of Health and providing vital logistical expertise transporting medical products to the Ukraine.
• > In Lithuania, the team have already worked with the Government to supply vital medicines to Ukraine; and after collaboration with the Lithuanian Ministry of Health and a third party organisation, it is now supplying vital medicines directly to the Lviv Children’s hospital in Ukraine.
• > Norway is making a significant financial donation of over 450,000 NOK ($50,000) to the Red Cross.
• > In Turkey as part of the company’s membership of the American Chamber of Commerce, our team is investigating how it can support with both humanitarian and medical requirements.  
• > Even in markets further away in geographical terms, colleagues, Alphega member pharmacies and partners are collaborating to plan additional support including further product donations.  
• > We take our responsibility to protect the international supply chain, serve our customers and patients, and make timely decisions seriously. As a business we remain 100% committed to ensuring continued supply and access to medicines and essential healthcare products to the communities across our network.

A perspective from Steve Collis, CEO of AmerisourceBergen can be found at: (8) Finding Solace in Insecurity – Reflecting on the Invasion of Ukraine | LinkedIn

Class 2 Recall - Diazepam Rectubes 2.5mg Rectal Solution

Wockhardt UK Ltd are recalling a batch of Diazepam RecTubes 2.5mg Rectal Solution due to an out of specification result for assay during routine stability testing.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-wockhardt-uk-ltd-diazepam-rectubes-2-dot-5mg-rectal-solution-el-22-a-slash-11?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ebb2ea59-2e04-4d36-ae96-7a763b1bac0f&utm_content=immediately

Further Information

For more information, medical or supply enquiries, please contact: drug.safety@wockhardt.co.uk

For stock control queries, please contact: customer.services@wockhardt.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Alliance Healthcare celebrates Thank You Day

Today (4 March) is being celebrated as Thank You Day at Alliance Healthcare and is about appreciating all our colleagues, (front line and beyond) as we stop and say thanks for all their hard work every day and especially during the pandemic. 

The event is taking place across all Alliance Healthcare countries, in support of World Appreciation Day, as recognised by our AmerisourceBergen colleagues. Celebratory events will be taking place across the business to get as many colleagues involved as possible.

Marie Evans, Managing Director, Alliance Healthcare is excited to be involved and told us:

“I am extremely grateful to all our committed team members across our entire organisation, from operations that pick and pack the medicines to fulfil customer orders, to our support services and sales teams across every site and function, those in the supply chain, product sourcing and to our 1,000+ driver colleagues who deliver these medicines to healthcare professionals across the UK. Today is about celebrating and recognising all that our team members do, for that I am truly grateful.”

Class 3 Recall - Isotard 60mg XL Tablets X 28

Kyowa Kirin Services Ltd are recalling the below batch of Isotard 60mg XL Tablets as a precautionary measure due to microfibres/crystals of the Active Pharmaceutical Ingredient (API) being present on the surface of the tablets as a result of sublimation.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-kyowa-kirin-services-ltd-isotard-60mg-xl-tablets-el-22-a-slash-10?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b4f8ccdb-aa09-4628-ba52-819224d0c0b3&utm_content=immediately

Further Information

For more information please contact:

Customer Services for stock control enquiries: Karen Murray karen.murray@kyowakirin.com +44 (0) 7712 001288 (Mobile)

Quality enquiries Martin Smith martin.smith@kyowakirin.com +44 (0)7904 671 807 (Mobile)

or for Medical Information enquiries: medinfo@kyowakirin.com

For Adverse Event reporting: medinfo@kyowakirin.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 Drug Caution In Use - Naprosyn Tablets (All Strengths), Naprosyn EC 250mg Gastro-Resistant Tablets, Naprosyn EC 500mg Gastro-Resistant Tablets

Atnahs Pharma UK Limited have identified additional missing information on the PIL of the certain product batches.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-atnahs-pharma-uk-limited-naprosyn-tablets-all-strengths-naprosyn-ec-500mg-gastro-resistant-tablets-el-22-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d1fe57c1-88a3-444b-acd2-2e861aa3fac2&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information queries or stock control queries, please contact: info@pharmanovia.com

If you have any questions, then please contact your local Service Centre Customer Services team.

Latest news from UKHSA: Lateral flow device (LFD) test kit distribution

England only:

Following the Prime Minister’s announcement on 21st February 2022 and the publication of the Government policy document – COVID-19 Response: Living with COVID-19 – free COVID-19 mass testing will end from 1st April 2022.

This means the last day on which the Pharmacy Collect service will operate will be 31st March 2022.

PSNC, the UK Health Security Agency (UKHSA) and NHS England and NHS Improvement are working together on the final plans for the end of the service.

Whilst over the last few days contractors have seen an unsurprising increase in requests for test kits and that has also increased the number of orders being placed with Alliance Healthcare, resulting in temporary out of stocks in some distribution centres, UKHSA has confirmed that they continue to have good stock levels.

To ensure an even distribution of lateral flow tests across the country, UKHSA are planning future deliveries across all test distribution channels. Alliance Healthcare’s last delivery of tests from the UKHSA warehouse will be on 18th March 2022. Pharmacies will be able to order for a short period of time after that date.

UKHSA ask that all orders for kits placed by contractors with Alliance Healthcare should be based on the current need, driven by demand from citizens, rather than trying to cover future demand.

Further details about the service end, including information on final payment claims, will be provided to contractors as soon as those details have been finalised.

Working together to support the patient

In the week following the introduction of the Living with Covid plan from government including the end to self- isolation regulations and an announcement on the end of free tests from 1st April, Alliance Healthcare and our pharmacy contractors have done a great job of meeting demand.

In England, Alliance Healthcare will have distributed over 6 million tests this week, meeting all orders from pharmacies.

There has been good availability of lateral flow device (LFD) test kits, and any temporary out of stock occurrence have been resolved on the same day. Indeed, UKHSA distributed over 7.5 million tests to Alliance Healthcare this week.

Information from Alliance Healthcare:

UK & NI:
Alliance Healthcare continue to work with the UKHSA on the distribution of lateral flow tests to support the Pharmacy Collect scheme.

For latest PIP codes please visit myahportal.co.uk